press release – price-sensitive

PRICE-SENSITIVE | NON PRICE-SENSITIVE

  • TURNOVER AS OF 31 DECEMBER 2023 EQUAL TO 3.3 MILLION EUROS

    TURNOVER AS OF 31 DECEMBER 2023 EQUAL TO 3.3 MILLION EUROS
    Go to the press release

  • CONCLUSION OF OWN SHARES BUY-BACK PROGRAM

    CONCLUSION OF OWN SHARES BUY-BACK PROGRAM
    Go to the press release

  • DIVIDEND DATE CORRECTION

    DIVIDEND DATE CORRECTION
    Go to the press release

  • THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF DECEMBER 31, 2022

    THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF DECEMBER 31, 2022
    Go to the press release

  • THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF DECEMBER 31, 2021

    THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF DECEMBER 31, 2021
    Go to the press release

  • ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING OF ARTERRA BIOSCIENCE S.P.A.

    ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF ARTERRA BIOSCIENCE S.P.A.
    Go to the press release

  • ARTERRA BIOSCIENCE WILL PARTICIPATE IN THE INVESTOR DAY ORGANIZED BY BANCA PROFILO ON APRIL 3 IN MILAN

    ARTERRA BIOSCIENCE WILL PARTICIPATE IN THE INVESTOR DAY ORGANIZED BY BANCA PROFILO ON APRIL 3 IN MILAN
    Go to the press release

  • ARTERRA COMMUNICATES THE CLOSURE OF THE THIRD EXERCISE PERIOD OF THE ARTERRA WARRANTS 2019-2022

    ARTERRA COMMUNICATES THE CLOSURE OF THE THIRD EXERCISE PERIOD OF THE ARTERRA WARRANTS 2019-2022
    Go to the press release

  • THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 2023

    THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 2023
    Go to the press release

  • ORDINARY SHAREHOLDERS’ MEETING OF ARTERRA BIOSCIENCE S.P.A.

    ORDINARY SHAREHOLDERS' MEETING OF ARTERRA BIOSCIENCE S.P.A.
    Go to the press release